[
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/VEGF-aptamer.html",
    "New Linker name":"VEGF aptamer",
    "Name":"Pegaptanib(Macugen)",
    "Target":"VEGF165",
    "Disease":"Age-related macular degeneration (AMD)",
    "Clinical Status":"FDA approved (2004)",
    "Sequence":"5'-GCGGAAUCAGUGAAUGCUUAUACAUCCGC-3'",
    "Length":29,
    "GC content":0.48,
    "Affinity":"Kd: 49±6 pM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/16647134\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Complement-component-5-aptamer.html",
    "New Linker name":"Complement component 5 aptamer",
    "Name":"Avacincaptad pegol (Izervay)",
    "Target":"Complement protein C5",
    "Disease":"Age-related macular degeneration (AMD)",
    "Clinical Status":"FDA approved (2023)",
    "Sequence":"5'-CGUCCCUUCGCAACCCUUUAAGACUUGGGACCCUGCUCUU-3'",
    "Length":40,
    "GC content":0.55,
    "Affinity":"Kd: 3.6 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/37696275\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Bovine-factor-IX-aptamer",
    "New Linker name":"Bovine factor IX aptamer",
    "Name":"Pegnivacogin",
    "Target":"Factor IX",
    "Disease":"Coronary Artery Disease",
    "Clinical Status":"Phase III",
    "Sequence":"5'-GGGAGCUCAGCCUUCACUGCCUACGCGGGCGUUUACGUAACGGCUUAUGGGGAGCUGAGCGCUUGACCGUGGUAGUGCUAAGCAGUAAACGAGGGCACCACGGUCGGAUCCAC-3'",
    "Length":114,
    "GC content":0.6018,
    "Affinity":"Kd: 10 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/21724623\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/L-CCL2-aptamer.html",
    "New Linker name":"\/L-CCL2 aptamer",
    "Name":"NOX-E36 (Emapticap pegol)",
    "Target":"CCL2",
    "Disease":"Type 2 diabetic patients with albuminuria",
    "Clinical Status":"Phase II",
    "Sequence":"5'-GCACGUCCCUCACCGGUGCAAGUGAAGCCGAGGCUCUGCG-3'",
    "Length":40,
    "GC content":0.67,
    "Affinity":"Kd: 1.40±0.16 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/28186566\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/bFGF-aptamer.html",
    "New Linker name":"bFGF aptamer",
    "Name":"RBM 007(Umedaptanib pegol)",
    "Target":"bFGF",
    "Disease":"Exudative age-related macular degeneration (nAMD)",
    "Clinical Status":"Phase II",
    "Sequence":"7A aptamer: 5'-AACGCUCAAUCGGCGAGCUAACCAAGACACUCGCUGCACUUCGACAUG-3'\n26A aptamer: 5'-AACGCUCAACGUCAGAAGGCAACGUAUAGGCAAGCACACUUCGACAUGAGGC-3'",
    "Length":"48\n52",
    "GC content":"54%\n52%",
    "Affinity":"Kd: 5±0.5 nM\nKd1: 0.19±0.02 nM (26A)\nKd2: 49±26 nM (26A)",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/38036609\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Thrombin-aptamer",
    "New Linker name":"Thrombin aptamer",
    "Name":"Apta-1",
    "Target":"Heparin-binding motif (Exosite II) on thrombin",
    "Disease":"Sepsis",
    "Clinical Status":"Phase I",
    "Sequence":"5'-GGGAACAAAGCUGAAGUACUUACCC-3'",
    "Length":25,
    "GC content":0.48,
    "Affinity":"Kd:  0.54±0.1 nM",
    "References":"https:\/\/onderzoekmetmensen.nl\/en\/trial\/51837"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/HER2-aptamer",
    "New Linker name":"HER2 aptamer",
    "Name":"H2EH3",
    "Target":"EGFR\/HER2\/HER3",
    "Disease":"Breast tumors",
    "Clinical Status":"Preclinical",
    "Sequence":"TSA14 aptamer: 5'-GCUGGAGCAUUUAUGGAUGAACCUUGGACGGAA-3'\nTSA12 aptamer: 5'-GAAAGUGAGAGUCGAUUUAGCAACAGAGAGUGAGG-3'",
    "Length":"33\n35",
    "GC content":"48%\n46%",
    "Affinity":"Kd:  133.9±12.78 nM\nKd: 191.9±21.77 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/29499944\/"
  }
]